Attana receives training order from a leading US research institute
Attana has received an order of a two day training course for a leading US research institute. The purpose of the training is to explore the potential use of Attana´s cell based technology within the research field of one of the world´s major diseases areas.
Attana’s senior application scientist will theoretically and practically educate two researchers of the benefits of Attana´s technology and how to practically set up assays. The training is a two day introduction course for two people and Attana receives around 150 kSEk for the training.
Attana´s Interrnational Sales Manager Thomas Ljungberg comments: “This order is of strategic importance for Attana, since we are now involved at an early stage in designing R&D projects for a major drug development project. The order shows a market acceptance for our technology and capability to characterize interactions with cells, tissues, viruses etc it also provides a value of our application knowledge and the advises we can provide.”
For more information, please contact:
Teodor Aastrup, CEO Attana AB
tel: + 46 8 674 57 00
The Board of directors for Attana consider that the information in this press release is not likely to have a significant effect on the share prices, but is of general interest for the shareholders and hence should be communicated.
Attana was founded in 2002 with the vision of in-vitro characterization of molecular interactions mimicking in-vivo conditions. Since then, Attana has developed proprietary label free biosensors for biochemical, crude, sera, and cell-based assays. Attana’s products and research services are used by Big Pharma, biotech companies and academic institutions within the life sciences. To learn more about Attana’s contract research services and our label free cell-based biosensors, please visit www.attana.com or contact email@example.com.